These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 26391880)

  • 1. Current status of pluripotent stem cells: moving the first therapies to the clinic.
    Kimbrel EA; Lanza R
    Nat Rev Drug Discov; 2015 Oct; 14(10):681-92. PubMed ID: 26391880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy.
    Ichimura H; Shiba Y
    Circ J; 2017 Jun; 81(7):929-935. PubMed ID: 28603177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinic.
    Whiting P; Kerby J; Coffey P; da Cruz L; McKernan R
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140375. PubMed ID: 26416684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery.
    Murata M; Tohyama S; Fukuda K
    Pharmacol Ther; 2010 May; 126(2):109-18. PubMed ID: 20156482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cells as a novel tool for drug screening and treatment of degenerative diseases.
    Zuba-Surma EK; Wojakowski W; Madeja Z; Ratajczak MZ
    Curr Pharm Des; 2012; 18(18):2644-56. PubMed ID: 22512442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
    Osakada F
    Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
    Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
    Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients With Ocular Disease.
    Leach LL; Clegg DO
    Stem Cells; 2015 Aug; 33(8):2363-73. PubMed ID: 25809736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotent stem cells: the last 10 years.
    Kimbrel EA; Lanza R
    Regen Med; 2016 Dec; 11(8):831-847. PubMed ID: 27908220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation and application of pluripotent stem cells for regenerative medicine.
    Wang J; Zhou Q
    Sci China Life Sci; 2016 Jun; 59(6):576-83. PubMed ID: 27225262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and Pig Pluripotent Stem Cells: From Cellular Products to Organogenesis and Beyond.
    Xuan Y; Petersen B; Liu P
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of pluripotent stem cells into retinal pigmented epithelium.
    Croze RH; Clegg DO
    Dev Ophthalmol; 2014; 53():81-96. PubMed ID: 24732763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients.
    Song WK; Park KM; Kim HJ; Lee JH; Choi J; Chong SY; Shim SH; Del Priore LV; Lanza R
    Stem Cell Reports; 2015 May; 4(5):860-72. PubMed ID: 25937371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD).
    Fields M; Cai H; Gong J; Del Priore L
    Cells; 2016 Dec; 5(4):. PubMed ID: 27941641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of pluripotent stem cells and their derivatives: current status and future perspectives.
    Pendse S; Vaidya A; Kale V
    Regen Med; 2022 Sep; 17(9):677-690. PubMed ID: 35703035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.
    Hartman ME; Dai DF; Laflamme MA
    Adv Drug Deliv Rev; 2016 Jan; 96():3-17. PubMed ID: 25980938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iPSC-RPE in Retinal Degeneration: Recent Advancements and Future Perspectives.
    Maeda T; Takahashi M
    Cold Spring Harb Perspect Med; 2023 Aug; 13(8):. PubMed ID: 36690464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.